This section establishes the foundational identification data for both the affected employee and the precise location where the exposure incident occurred. Accurate completion is critical for contact tracing, facility risk assessment, and regulatory documentation.
Employee Full Legal Name
Employee Unique Identification Number
Employment Classification
Full-time Permanent
Part-time Permanent
Temporary/Contract
Locum/Tenens
Student/Trainee
Volunteer
Primary Job Title/Role
Department/Unit Assignment
Direct Supervisor Name
Supervisor Contact Number
Date and Time of Exposure Incident
Date and Time of Initial Report Submission
Healthcare Facility Legal Entity Name
Facility Department/Division Where Incident Occurred
Specific Room/Area Identifier
Complete Facility Address Including Floor/Building Wing
Were there any witnesses to the exposure incident?
This section requires meticulous documentation of the precise mechanism of exposure, the nature of the biohazardous material, and the contextual factors that contributed to the incident. This data drives root cause analysis and prevention strategies.
Primary Exposure Route/Mechanism
Percutaneous injury (needlestick, cut with sharp object)
Mucous membrane exposure (splash to eye, nose, mouth)
Non-intact skin contact (exposure to broken skin, abrasion)
Human bite breaking skin
Other exposure mechanism
Contaminated Device or Vector Involved
Hypodermic needle
Suture needle
Scalpel or other sharp blade
Broken glassware/vial
Contaminated sharp instrument
Splash without sharp device
Blood/body fluid on contaminated surface
Aerosol generating procedure
Other vector
Was this device safety-engineered or equipped with injury prevention mechanism?
Biohazardous Material Source Origin
Known infected patient/source
Patient with unknown infection status
Clinical specimen/sample
Research material
Environmental contamination
Unknown/unidentified source
Suspected or Known Bloodborne Pathogen(s) Involved (Select all that apply)
Hepatitis B Virus (HBV)
Hepatitis C Virus (HCV)
Human Immunodeficiency Virus (HIV)
Other bloodborne pathogen
Unknown pathogen type
If other bloodborne pathogen, specify organism and known resistance profile:
Material Type Exposure
Whole blood
Blood products (plasma, serum)
Bloody fluid/tissue
Cerebrospinal fluid
Synovial fluid
Pleural fluid
Peritoneal fluid
Pericardial fluid
Amniotic fluid
Semen/vaginal secretions
Saliva with visible blood
Other potentially infectious material
Estimated Volume of Exposure Material
Detailed Description of Exposure Event Circumstances
Incident Classification
Routine procedure deviation
Emergency/uncontrolled situation
Equipment failure/malfunction
Lack of appropriate safety device
PPE breach/failure
Human factor error
Training deficiency
Policy/protocol violation
Other classification
Personal Protective Equipment (PPE) Utilized at Time of Exposure (Select all that apply)
Double gloves
Face shield/safety goggles
Surgical mask/N95 respirator
Fluid-resistant gown
Closed-toe protective footwear
No PPE utilized
PPE utilized but breached
Were engineering controls (e.g., safety needles, sharps containers, splash guards) available and functional?
Exposure Severity Risk Score (1=Minimal, 5=Extreme High Risk)
Document all immediate post-exposure actions, medical evaluations, and initial treatment interventions. Time-sensitive interventions are critical for infection prevention.
Time First Aid Was Initiated Post-Exposure
Immediate First Aid Measures Administered (Select all applicable)
Wound washing with soap and water
Antiseptic application (iodine, chlorhexidine)
Eye irrigation with sterile saline or water
Mouth rinsing with antiseptic solution
Bleeding control with clean dressing
No first aid provided
Other first aid intervention
Detailed First Aid Procedure Description and Duration:
Was the exposed employee evaluated by medical professional within 2 hours?
Name and Credentials of First Evaluating Healthcare Provider
Time of Initial Medical Evaluation
Location of Initial Medical Evaluation
Baseline Laboratory Tests Obtained at Initial Evaluation (Select all)
HIV antigen/antibody immunoassay
Hepatitis B surface antigen (HBsAg)
Hepatitis B surface antibody (anti-HBs)
Hepatitis C antibody (anti-HCV)
Hepatitis C RNA (if anti-HCV positive)
Complete blood count
Liver function panel
No baseline testing obtained
Baseline Test Results Summary or Pending Status:
Description of Exposure Site Wound or Injury Severity:
Was tetanus prophylaxis indicated and administered?
Additional Acute Medical Treatment Provided:
Employee's Pain Level at Initial Evaluation (0=No Pain, 10=Severe Pain)
This section establishes the complete post-exposure management protocol including prophylaxis decisions, source testing, and longitudinal follow-up schedule. Compliance monitoring and outcome tracking are essential components.
Was Post-Exposure Prophylaxis (PEP) Recommended by Occupational Health?
If PEP Initiated, Time to First Dose Post-Exposure
Did employee consent to and complete PEP regimen?
Was source testing for bloodborne pathogens performed?
Employee Follow-Up Testing Schedule and Results Tracking
Test Timepoint | Scheduled Date | Actual Date Completed | Tests Performed | Results Summary | Employee Notified of Results | |
|---|---|---|---|---|---|---|
Baseline | 1/15/2024 | 1/15/2024 | HIV Ag/Ab, HBsAg, anti-HCV | All negative | Yes | |
6 Weeks | 2/26/2024 | HIV Ag/Ab | Pending | |||
12 Weeks | 4/8/2024 | HIV Ag/Ab, anti-HCV | Pending | |||
6 Months | 7/15/2024 | HIV Ag/Ab, HBsAg, anti-HCV | Pending | |||
Was employee provided with counseling and psychosocial support services?
Did employee experience any PEP-related adverse events?
Was work restriction or modified duty required during follow-up period?
Additional Post-Exposure Management Notes and Observations:
Final review, clinical oversight, and authority sign-off section. This validates that appropriate medical management has been provided and that environmental/organizational corrective actions have been implemented to prevent recurrence.
Occupational Health Physician Name and Credentials
Physician Review Date and Time
Physician Clinical Assessment of Exposure Risk (Select one)
High-risk exposure requiring intensive follow-up
Moderate-risk exposure requiring standard follow-up
Low-risk exposure requiring minimal follow-up
Negligible risk - no follow-up required
Physician's Clinical Recommendations and Medical Opinions:
Does physician recommend incident review by infection control committee?
Occupational Health Physician Electronic/Physical Signature
Environmental Health & Safety (EHS) Director Name and Credentials
EHS Director Review Date and Time
Root Cause Analysis Findings (Select all that apply)
Engineering control failure/absence
Work practice deficiency
PPE non-compliance or inappropriate use
Training inadequacy
Policy/protocol unclear or absent
Human factor error
Equipment malfunction
Environmental factor
No systemic cause identified - isolated incident
EHS Director's Description of Corrective Actions Implemented:
Has a workplace safety alert or bulletin been issued to prevent similar incidents?
Will this incident trigger formal safety audit or inspection?
EHS Director Electronic/Physical Signature
Final Incident Classification and Disposition
Closed - standard follow-up in progress
Closed - no follow-up required
Open - awaiting test results
Open - PEP compliance monitoring
Referred for disciplinary review
Under investigation for legal/regulatory reporting
Additional Administrative Notes and Cross-References: